(Q48158598)

9 February 2018

title

PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain (English)

1 reference

9 February 2018

7

W D Heiss

1 reference

9 February 2018

author name string

H H Coenen

1

1 reference

9 February 2018

K Wienhard

2

1 reference

9 February 2018

G Stöcklin

3

1 reference

9 February 2018

P Laufer

4

1 reference

9 February 2018

I Hebold

5

1 reference

9 February 2018

G Pawlik

6

1 reference

9 February 2018

publication date

1 January 1988

1 reference

9 February 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

9 February 2018

volume

14

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

80-87

1 reference

9 February 2018

Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors

cites work

1 reference

12 December 2020

Neurotransmitter receptors-biochemistry and alterations in nueropsychiatric disorders

1 reference

12 December 2020

Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions

1 reference

12 December 2020

Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens

1 reference

12 December 2020

Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

12 December 2020

The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors

1 reference

12 December 2020

Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.

1 reference

12 December 2020

Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues

1 reference

12 December 2020

Imaging dopamine receptors in the human brain by positron tomography

1 reference

12 December 2020

No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography

1 reference

12 December 2020

Characterization and regional distribution of serotonin S2-receptors in human brain

1 reference

12 December 2020

Pituitary localization of 3H-spiroperidol by an uptake/storage mechanism?

1 reference

12 December 2020

Atlas of dopamine receptor images (PET) of the human brain.

1 reference

12 December 2020

Receptor-mediated endocytosis of hormones in cultured cells

1 reference

12 December 2020

In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.

1 reference

12 December 2020

The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production.

1 reference

12 December 2020

[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain

1 reference

12 December 2020

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy

1 reference

12 December 2020

3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet

1 reference

12 December 2020

Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor

1 reference

12 December 2020

D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis).

1 reference

12 December 2020

Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives

1 reference

12 December 2020

Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain

1 reference

12 December 2020

The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain

1 reference

12 December 2020

Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography

1 reference

12 December 2020

Dopamine receptor binding in vivo: The feasibility of autoradiographic studies

1 reference

12 December 2020

Exogenous l-dopa alters spiroperidol binding, in vivo, in the mouse striatum

1 reference

12 December 2020

3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regions

1 reference

12 December 2020

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

12 December 2020

Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches

1 reference

12 December 2020

76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00253446

1 reference

9 February 2018

1 reference

9 February 2018